SMMT FY 2025 Earnings — Summit Therapeutics Inc. Revenue & Financial Results | Market Cap Arena

SMMTSummit Therapeutics Inc.

$12B

FY 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$108,355

Operating Income

-$812M

Net Income

-$1.1B

EPS (Diluted)

$-1.44

Cash Flow

Operating Cash Flow

-$323M

Free Cash Flow

-$324M

Stock-Based Comp.

$732M

Balance Sheet

Total Assets

$751M

Total Liabilities

$92M

Stockholders' Equity

$659M

Cash & Equivalents

$225M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$108,355	-$15M	+99.3%
Operating Income	-$812M	$313,000	-259600.9%
Net Income	-$1.1B	-$221M	-387.8%